ARCTArcturus Therapeutics Holdings Inc.

ARCT Stock Price, Valuation & Chart | Arcturus Therapeutics Holdings Inc.

Compare

$16.740+0.52 (+3.17%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology ARCT intrinsic value ARCT calculated fair value vs price

Overview Financials Dividends Ratios

ARCT Historical price chart

ARCT Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization475.80M

PE Ratio-5.06

EPS-3.31

Trading Volume2.02M

Today's High/Low17.75/15.46

Dividend Yield0.00

52 Week High/Low24.17/5.5

Shares Outstanding28.42M

ARCT Financial Statement

ARCT Analyst ratings

ARCT Analysis & performance metrics

ARCT Company profile

Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United…

Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lung disease caused by mutations in cystic…

ARCT Management team

Name

Position

Igor Smolenov M.D., Ph.D.

Chief Development Officer

Lance Kurata

Chief Legal Officer

Joseph E. Payne M.Sc.CEO

Founder, President, Chief Executive Officer & Director

Padmanabh Chivukula Ph.D.COO

Founder, Chief Scientific Officer, Chief Operating Officer & Secretary

Neda Safarzadeh

Vice President and Head of IR/PR & Marketing

Kevin T. Skol

Chief Business Officer

Roberta Duncan

Chief Strategy Officer

Andrew H. Sassine MBACFO

Chief Financial Officer & Director

Name

Position

Igor Smolenov M.D., Ph.D.

Chief Development Officer

Lance Kurata

Chief Legal Officer

Joseph E. Payne M.Sc.CEO

Founder, President, Chief Executive Officer & Director

Padmanabh Chivukula Ph.D.COO

Founder, Chief Scientific Officer, Chief Operating Officer & Secretary

Neda Safarzadeh

Vice President and Head of IR/PR & Marketing

Kevin T. Skol

Chief Business Officer

Roberta Duncan

Chief Strategy Officer

Andrew H. Sassine MBACFO

Chief Financial Officer & Director

Management Team

Igor Smolenov M.D., Ph.D.

Chief Development Officer

Lance Kurata

Chief Legal Officer

Joseph E. Payne M.Sc.CEO

Founder, President, Chief Executive Officer & Director

Padmanabh Chivukula Ph.D.COO

Founder, Chief Scientific Officer, Chief Operating Officer & Secretary

Neda Safarzadeh

Vice President and Head of IR/PR & Marketing

Kevin T. Skol

Chief Business Officer

Roberta Duncan

Chief Strategy Officer

Andrew H. Sassine MBACFO

Chief Financial Officer & Director

Management

Igor Smolenov M.D., Ph.D.

Chief Development Officer

Lance Kurata

Chief Legal Officer

Joseph E. Payne M.Sc.CEO

Founder, President, Chief Executive Officer & Director

Padmanabh Chivukula Ph.D.COO

Founder, Chief Scientific Officer, Chief Operating Officer & Secretary

Neda Safarzadeh

Vice President and Head of IR/PR & Marketing

Kevin T. Skol

Chief Business Officer

Roberta Duncan

Chief Strategy Officer

Andrew H. Sassine MBACFO

Chief Financial Officer & Director

Total 8 executives

ARCT Frequently asked questions

What is Arcturus Therapeutics Holdings Inc. (ARCT) Stock Price?

Current stock price of Arcturus Therapeutics Holdings Inc. (ARCT) stock is $16.740. The stock price is +3.17% higher in the session. The intraday range can be seen from this page. Volume of Arcturus Therapeutics Holdings Inc. (ARCT) stock is 2.02M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Arcturus Therapeutics Holdings Inc. (ARCT) stock price going up or down today?

The stock price of Arcturus Therapeutics Holdings Inc. (ARCT) can change with earnings, company news, and overall market sentiment. Arcturus Therapeutics Holdings Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Arcturus Therapeutics Holdings Inc. stock expensive at its current price?

Whether Arcturus Therapeutics Holdings Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ARCT on this page is -5.06. EPS on this page is -3.31. Compare those figures with peers and growth expectations before deciding if the current Arcturus Therapeutics Holdings Inc. price is justified.

How has the stock price of Arcturus Therapeutics Holdings Inc. (ARCT) performed historically?

Historical performance for Arcturus Therapeutics Holdings Inc. (ARCT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ARCT reacted to past earnings and market events.

Should I buy Arcturus Therapeutics Holdings Inc. (ARCT) stock, at this price?

Buying Arcturus Therapeutics Holdings Inc. (ARCT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.